Nonmedical Use of Antihistaminergic Anxiolytics and Other Prescription Drugs among Persons with Opioid Dependence

Table 6

Usual ways of acquiring prescription drugs (not mutually exclusive) among people reporting lifetime use of each substance, respectively. n (% of lifetime users/% of study sample).

	Benzodiazepines	Pregabalin	z-drugs	Promethazine	Hydroxyzine	Alimemazine	Prescription opioids	Prescription stimulants
Current	8/62 (13%)	5/26 (19%)	12/62 (19%)	22/50 (44%)	12/45 (27%)	12/52 (23%)	12/60 (20%)	7/24 (29%)
Usual acquisition through	13/62 (21%)	9/26 (35%)	23/62 (37%)	32/50 (64%)	29/45 (64%)	34/52 (65%)	19/60 (32%)	12/24 (50%)
Usual acquisition from black	50/62 (81%)	12/26 (46%)	38/62 (61%)	3/50 (6%)	3/45 (7%)	5/52 (10%)	43/60 (72%)	9/24 (38%)
Other usual	6/62 (10%)	4/26 (15%)	7/62 (11%)	12/50 (24%)	7/45 (16%)	9/52 (17%)	1/60 (2%)	4/24 (17%)
Gift	2	4	3	3	1	3	1	3
In treatment	1	—	3	9	6	5	—	—
Facility/prison
Ever approached by someone trying to sell prescription	57 (78%)	31 (43%)	51 (70%)	6 (8%)	7 (10%)	6 (8%)	52 (71%)	23 (32%)
n (% of 73)

values for benzodiazepines and prescription stimulants; for hydroxyzine and prescription opioids; for alimemazine; and for promethazine.
values for pregabalin and prescription stimulants; for benzodiazepines; for z-drugs and promethazine; for alimemazine and prescription opioids; and for hydroxyzine.
values for z-drugs; for hydroxyzine, alimemazine, prescription opioids, and prescription stimulants; for promethazine; and for benzodiazepines.